Biosenta Inc.
ZRO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 300.00 | -146.10K | 146.30K | 100.00 | 100.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 300.00 | -146.10K | 146.30K | 100.00 | 100.00 |
| Cost of Revenue | 100.00 | 200.00 | 100.00 | 100.00 | 100.00 |
| Gross Profit | 200.00 | -146.20K | 146.30K | 100.00 | 100.00 |
| SG&A Expenses | 177.90K | 202.80K | 269.90K | 124.10K | 181.40K |
| Depreciation & Amortization | 500.00 | 500.00 | 500.00 | 1.20K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 182.70K | 210.40K | 280.90K | 137.70K | 182.30K |
| Operating Income | -182.30K | -356.40K | -134.50K | -137.50K | -182.20K |
| Income Before Tax | -419.70K | -523.60K | -400.00K | -367.20K | -346.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -419.70K | -523.60K | -400.00K | -367.20K | -346.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -419.70K | -523.60K | -400.00K | -367.20K | -346.30K |
| EBIT | -182.30K | -356.40K | -134.50K | -137.50K | -182.20K |
| EBITDA | -181.90K | -355.90K | -134.00K | -137.00K | -- |
| EPS Basic | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 32.45M | 31.89M | 28.78M | 27.48M | 26.46M |
| Average Diluted Shares Outstanding | 32.45M | 31.89M | 28.78M | 27.48M | 26.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |